| Fiscal period | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|
| Period End Date | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 |
|---|
| Product revenue | 112.82 | 119.91 | 166.66 | 156.24 | 147.79 | 130.46 | 114.51 | 105.53 | 107.78 | 102.93 |
| Licensing, milestone and contract revenue | -- | -- | -- | -- | -- | -- | 0.10 | 0.02 | 5.64 | 0.45 |
| Total Revenues | 112.82 | 119.91 | 166.66 | 156.24 | 147.79 | 130.46 | 114.61 | 105.56 | 113.42 | 103.38 |
| Cost of product revenue | 49.01 | 43.91 | 63.57 | 62.66 | 64.85 | 61.43 | 28.75 | 31.28 | 27.36 | 24.03 |
| Gross Profit | 63.81 | 76.00 | 103.09 | 93.58 | 82.94 | 69.03 | -- | -- | -- | -- |
| Goodwill impairment | -- | -- | -- | -- | -- | 42.52 | -- | -- | -- | -- |
| Research & development | 25.77 | 25.54 | 32.69 | 28.18 | 27.33 | 23.43 | 16.67 | 18.19 | 18.79 | 10.73 |
| Selling, general & administrative | 49.09 | 55.56 | 95.85 | 84.79 | 74.10 | 60.06 | 34.95 | 34.34 | 21.54 | 18.01 |
| Restructuring charges | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Acquisition-related expenses | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Impairment of intangible assets | -- | -- | (62.19) | -- | -- | -- | -- | -- | -- | -- |
| Litigation settlement costs | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Change in fair value of contingent consideration | -- | -- | -- | -- | 21.10 | 28.67 | -- | -- | -- | -- |
| Total Operating Expenses | 74.86 | 81.10 | 190.73 | 112.98 | 80.33 | 97.35 | 80.36 | 83.81 | 67.69 | 52.77 |
| Operating Income (Loss) | (11.05) | (5.10) | (87.64) | (19.40) | 2.62 | (28.32) | 34.25 | 21.75 | 45.73 | 50.61 |
| Interest income, net | 1.74 | 2.34 | 2.31 | 0.65 | (0.19) | (0.30) | 1.87 | 1.46 | 0.47 | 0.26 |
| Income (loss) before income taxes | (9.31) | (2.76) | (85.33) | (18.75) | 2.43 | (28.62) | 36.12 | 23.21 | 46.20 | 50.87 |
| Current: Federal | 0.18 | 4.04 | 3.15 | 1.01 | 0.49 | 0.36 | 6.25 | 4.78 | 12.61 | 14.98 |
| Current: State | 0.19 | 1.37 | 0.31 | 0.29 | (0.64) | (1.97) | 1.88 | 1.64 | 2.74 | 3.27 |
| Provision for income taxes | 0.67 | 6.06 | (2.66) | (3.89) | (1.71) | (4.64) | 8.93 | 4.49 | 14.39 | 18.32 |
| Deferred: Federal | -- | -- | (5.05) | (3.24) | (0.55) | (1.98) | 1.09 | (0.99) | (0.43) | (0.07) |
| Deferred: State | -- | -- | (1.42) | (1.26) | (0.43) | (1.07) | 0.32 | (0.15) | (0.07) | (0.08) |
| Deferred: Foreign | 0.06 | 0.23 | 0.03 | (0.77) | (0.75) | (0.03) | (0.81) | (1.20) | (0.50) | (0.07) |
| Current- Foreign | 0.25 | 0.42 | 0.31 | 0.10 | 0.17 | 0.05 | 0.20 | 0.41 | 0.03 | 0.30 |
| Benefit from release of valuation allowance | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Benefit from release of valuation allowance: Federal | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Benefit from release of valuation allowance: State | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Loss from continuing operations | (9.98) | (8.83) | -- | -- | -- | -- | -- | -- | -- | -- |
| Loss from discontinued operations | (0.90) | (47.56) | -- | -- | -- | -- | -- | -- | -- | -- |
| Income Before Extraordinary Income & Accounting Change | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income (Loss) Available to Common Shareholders | (10.88) | (56.39) | (82.67) | (14.86) | 4.13 | (23.98) | 27.19 | 18.72 | 31.82 | 32.55 |
| Basic: Income (loss) before cumulative effect of change in accounting principle | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Basic: Continuing Operations | (0.70) | (0.60) | -- | -- | -- | -- | -- | -- | -- | -- |
| Basic: Discontinued Operations | (0.06) | (3.23) | -- | -- | -- | -- | -- | -- | -- | -- |
| Basic: Net income per share | (0.76) | (3.83) | (5.64) | (1.02) | 0.29 | (1.69) | 1.93 | 1.30 | 2.18 | 2.22 |
| Diluted: Income (loss) before cumulative effect of change in accounting principle | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Diluted: Continuing operations | (0.70) | (0.60) | -- | -- | -- | -- | -- | -- | -- | -- |
| Diluted: Discontinued operations | (0.06) | (3.23) | -- | -- | -- | -- | -- | -- | -- | -- |
| Diluted net income (loss) per share | (0.76) | (3.83) | (5.64) | (1.02) | 0.28 | (1.69) | 1.89 | 1.27 | 2.11 | 2.15 |
| Basic weighted average common shares outstanding | 14.34 | 14.72 | 14.66 | 14.56 | 14.40 | 14.22 | 14.12 | 14.44 | 14.58 | 14.68 |
| Diluted weighted average common shares outstanding | 14.34 | 14.72 | 14.66 | 14.56 | 14.63 | 14.22 | 14.37 | 14.69 | 15.07 | 15.12 |